InvestorsHub Logo
Followers 260
Posts 18186
Boards Moderated 0
Alias Born 01/19/2006

Re: DewDiligence post# 14045

Monday, 01/23/2017 9:09:53 AM

Monday, January 23, 2017 9:09:53 AM

Post# of 29596
Dew, I will be surprised if all of the companies you mention in your post, along with JNJ that is also active in joint therapy, do not find VCEL an attractive buyout candidate in light of its recently FDA-approved MACI technology---take a look.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.